Characterization of a clonal human colon adenocarcinoma line intrinsically resistant to doxorubicin
1997

Study of Drug Resistance in Colon Cancer Cells

publication Evidence: moderate

Author Information

Author(s): E Dolfini, T Dasdial, G Arancia, A Molinari, A Calcabrini, RJ Scheper, MJ Flens, MB Gariboldi, E Monti

Primary Institution: University of Milano

Hypothesis

The study aims to characterize a clonal human colon adenocarcinoma line that is intrinsically resistant to doxorubicin.

Conclusion

The study found that increased expression of MRP and alterations in drug distribution contribute to the intrinsic resistance of LoVo/C7 cells to doxorubicin.

Supporting Evidence

  • LoVo/C7 cells showed increased expression of MRP, which is associated with drug resistance.
  • Alterations in the subcellular distribution of doxorubicin were observed in LoVo/C7 cells.
  • Changes in PKC isoform patterns were detected in both intrinsically and pharmacologically resistant cells.

Takeaway

Some colon cancer cells can resist treatment with a common drug called doxorubicin, and this study looked at why that happens.

Methodology

The study involved isolating two monoclonal lines from LoVo human colon adenocarcinoma cells and assessing various proteins related to drug resistance.

Limitations

The study primarily focuses on in vitro models, which may not fully represent in vivo conditions.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication